Spleen deposition of Cryptococcus neoformans capsular glucuronoxylomannan in rodents occurs in red pulp macrophages and not marginal zone macrophages expressing the C-type lectin SIGN-R1

References

• Goldman DL, Lee SC, Casadevall A. Tissue localization of Cryptococcus neoformans glucuronoxylomannan in the presence and absence of specific antibody. Infect Immun 1995; 63: 3448–3453
   PubMed Web of Science ®Google Scholar
• Monari C, Bistoni F, Vecchiarelli A. Glucuronoxylomannan exhibits potent immunosuppressive properties. FEMS Yeast Res 2006; 6: 537–542
   Google Scholar
• Lendvai N, Casadevall A, Liang Z, et al. Effect of immune mechanisms on the pharmacokinetics and organ distribution of cryptococcal polysaccharide. J Infect Dis 1998; 177: 1647–1659
   PubMed Web of Science ®Google Scholar
• Kang YS, Kim JY, Bruening SA, et al. The C-type lectin SIGN-R1 mediates uptake of the capsular polysaccharide of Streptococcus pneumoniae in the marginal zone of mouse spleen. Proc Natl Acad Sci USA 2004; 101: 215–220
   PubMedGoogle Scholar
• Baker PJ. T cell regulation of the antibody response to bacterial polysaccharide antigens: an examination of some general characteristics and their implications. J Infect Dis 1992; 165(Suppl. 1)S44–48
   Google Scholar
• Pirofski LA, Casadevall A. Cryptococcus neoformans: paradigm for the role of antibody immunity against fungi?. Zentralbl Bakteriol 1996; 284: 475–495
   PubMedGoogle Scholar
• Maitta RW, Datta K, Lees A, Belouski SS, Pirofski LA. Immunogenicity and efficacy of Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan peptide mimotope-protein conjugates in human immunoglobulin transgenic mice. Infect Immun 2004; 72: 196–208
   Google Scholar
• Cherniak R, Sundstrom JB. Polysaccharide antigens of the capsule of Cryptococcus neoformans. Infect Immun 1994; 62: 1507–1512
   PubMed Web of Science ®Google Scholar
• De Jesus M, Hackett E, Durkin M, et al. Galactoxylomannan does not exhibit cross-reactivity in the platelia Aspergillus enzyme immunoassay. Clin Vaccine Immunol 2007; 14: 624–627
   PubMedGoogle Scholar
• Murphy JW, Cozad GC. Immunological unresponsiveness induced by cryptococcal capsular polysaccharide assayed by the hemolytic plaque technique. Infect Immun 1972; 5: 896–901
   PubMed Web of Science ®Google Scholar
• Kozel TR, Gotschlich EC. The capsule of Cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages. J Immunol 1982; 129: 1675–1680
   PubMed Web of Science ®Google Scholar
• Monari C, Pericolini E, Bistoni G, et al. Cryptococcus neoformans capsular glucuronoxylomannan induces expression of fas ligand in macrophages. J Immunol 2005; 174: 3461–3468
   PubMed Web of Science ®Google Scholar
• Syme RM, Bruno TF, Kozel TR, Mody CH. The capsule of Cryptococcus neoformans reduces T-lymphocyte proliferation by reducing phagocytosis, which can be restored with anticapsular antibody. Infect Immun 1999; 67: 4620–4627
   PubMed Web of Science ®Google Scholar
• Lanoue A, Clatworthy MR, Smith P, et al. SIGN-R1 contributes to protection against lethal pneumococcal infection in mice. J Exp Med 2004; 200: 1383–1393
   PubMed Web of Science ®Google Scholar
• Kraal G, Mebius R. New insights into the cell biology of the marginal zone of the spleen. Int Rev Cytol 2006; 250: 175–215
   Google Scholar
• Kraal G. Cells in the marginal zone of the spleen. Int Rev Cytol 1992; 132: 31–73
   PubMedGoogle Scholar
• van der Laan LJ, Dopp EA, Haworth R, et al. Regulation and functional involvement of macrophage scavenger receptor MARCO in clearance of bacteria in vivo. J Immunol 1999; 162: 939–947
   PubMed Web of Science ®Google Scholar
• Humphrey, JH, aGD. Different macrophage populations distinguished by means of fluorescent polysaccharides. Recognition and properties of marginal zone macrophages. Eur J Immunol 1981; 11: 221–228.
   PubMed Web of Science ®Google Scholar
• Taylor PR, Martinez-Pomares L, Stacey M, et al. Macrophage receptors and immune recognition. Annu Rev Immunol 2005; 23: 901–944
   PubMed Web of Science ®Google Scholar
• Kraal G, Ter Hart H, Meelhuizen C, Venneker G, Claassen E. Marginal zone macrophages and their role in the immune response against T-independent type 2 antigens: modulation of the cells with specific antibody. Eur J Immunol 1989; 19: 675–680
   PubMedGoogle Scholar
• Kang YS, Yamazaki S, Iyoda T, et al. SIGN-R1, a novel C-type lectin expressed by marginal zone macrophages in spleen, mediates uptake of the polysaccharide dextran. Int Immunol 2003; 15: 177–186
   Google Scholar
• Galustian C, Park CG, Chai W, et al. High and low affinity carbohydrate ligands revealed for murine SIGN-R1 by carbohydrate array and cell binding approaches, and differing specificities for SIGN-R3 and langerin. Int Immunol 2004; 16: 853–866
   Google Scholar
• Kang YS, Do Y, Lee HK, et al. A dominant complement fixation pathway for pneumococcal polysaccharides initiated by SIGN-R1 interacting with C1q. Cell 2006; 125: 47–58
   PubMedGoogle Scholar
• Grinsell M, Weinhold LC, Cutler JE, Han Y, Kozel TR. In vivo clearance of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans: a critical role for tissue macrophages. J Infect Dis 2001; 184: 479–487
   PubMed Web of Science ®Google Scholar
• Monari C, Bistoni F, Casadevall A, et al. Glucuronoxylomannan, a microbial compound, regulates expression of costimulatory molecules and production of cytokines in macrophages. J Infect Dis 2005; 191: 127–137
   Google Scholar
• Ellerbroek PM, Ulfman LH, Hoepelman AI, Coenjaerts FE. Cryptococcal glucuronoxylomannan interferes with neutrophil rolling on the endothelium. Cell Microbiol 2004; 6: 581–592
   PubMed Web of Science ®Google Scholar
• Yauch LE, Mansour MK, Shoham S, Rottman JB, Levitz SM. Involvement of CD14, toll-like receptors 2 and 4, and MyD88 in the host response to the fungal pathogen Cryptococcus neoformans in vivo. Infect Immun 2004; 72: 5373–5382
   PubMed Web of Science ®Google Scholar
• Cherniak R, Jones RG, Reiss E. Structure determination of Cryptococcus neoformans serotype A-variant glucuronoxylomannan by 13C-n.m.r. spectroscopy. Carbohydr Res 1988; 172: 113–138
   PubMed Web of Science ®Google Scholar
• Cherniak R, Reiss R., Turner SH. A galactoxylomannan antigen of Cryptococcus neoformans Serotype A. Carbohydr Res 1982; 103: 239–250
   Web of Science ®Google Scholar
• Goldman D, Lee SC, Casadevall A. Pathogenesis of pulmonary Cryptococcus neoformans infection in the rat. Infect Immun 1994; 62: 4755–4761
   PubMed Web of Science ®Google Scholar
• Tucker SC, Casadevall A. Replication of Cryptococcus neoformans in macrophages is accompanied by phagosomal permeabilization and accumulation of vesicles containing polysaccharide in the cytoplasm. Proc Natl Acad Sci USA 2002; 99: 3165–3170
   PubMed Web of Science ®Google Scholar
• Brown GD, Taylor PR, Reid DM, et al. Dectin-1 is a major beta-glucan receptor on macrophages. J Exp Med 2002; 196: 407–412
   PubMed Web of Science ®Google Scholar
• Schaller E, Macfarlane AJ, Rupec RA, et al. Inactivation of the F4/80 glycoprotein in the mouse germ line. Mol Cell Biol 2002; 22: 8035–8043
   PubMedGoogle Scholar
• Dijkstra CD, Van Vliet E, Dopp EA, van der Lelij AA, Kraal G. Marginal zone macrophages identified by a monoclonal antibody: characterization of immuno- and enzyme-histochemical properties and functional capacities. Immunology 1985; 55: 23–30
   PubMed Web of Science ®Google Scholar
• Casadevall A, Mukherjee J, Scharff MD. Monoclonal antibody based ELISAs for cryptococcal polysaccharide. J Immunol Methods 1992; 154: 27–35
   PubMed Web of Science ®Google Scholar
• Taylor PR, Brown GD, Herre J, et al. The role of SIGNR1 and the beta-glucan receptor (dectin-1) in the nonopsonic recognition of yeast by specific macrophages. J Immunol 2004; 172: 1157–1162
   PubMed Web of Science ®Google Scholar
• Mebius RE, Kraal G. Structure and function of the spleen. Nat Rev Immunol 2005; 5: 606–616
   PubMed Web of Science ®Google Scholar
• Ellerbroek PM, Walenkamp AM, Hoepelman AI, Coenjaerts FE. Effects of the capsular polysaccharides of Cryptococcus neoformans on phagocyte migration and inflammatory mediators. Curr Med Chem 2004; 11: 253–266
   PubMed Web of Science ®Google Scholar
• Muchmore HG, Scott EN, Felton FG, Fromtling RA. Cryptococcal capsular polysaccharide clearance in nonimmune mice. Mycopathologia 1982; 78: 41–45
   Google Scholar
• McFadden DC, De Jesus M, Casadevall A. The physical properties of the capsular polysaccharides from Cryptococcus neoformans suggest features for capsule construction. J Biol Chem 2006; 281: 1868–1875
   PubMed Web of Science ®Google Scholar
• Monari C, Retini C, Casadevall A, et al. Differences in outcome of the interaction between Cryptococcus neoformans glucuronoxylomannan and human monocytes and neutrophils. Eur J Immunol 2003; 33: 1041–1051
   PubMedGoogle Scholar